National Microbiome Initiative Launched

The White House announces a new effort to study diverse microbial communities around the planet.

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Gut bacteria in miceFLICKR, NIAIDThe White House today (May 13) announced the launch of a National Microbiome Initiative to support research on the microorganisms that live in or on the human body, plants, and other ecosystems, to provide a better understanding of their role in human and environmental health. The project’s goals are to support fundamental research, develop new technologies, and engage more people in this field, according to the Office of Science and Technology Policy (OSTP).

“This is a great day of celebration for everybody in this field,” J. Craig Venter, founder and CEO of the J. Craig Venter Institute, said during a press briefing held at the White House.

Heeding a call from scientists last year for a moonshot effort akin to the BRAIN Initiative, the federal government plans to invest $121 million in the new microbiome initiative for fiscal years 2016 and 2017. This amount includes $20 million from the National Institutes of Health (NIH), $16 million from the National Science Foundation (NSF), $12.5 million from NASA, $10 million from the Department of Energy, and a total of $23.9 million from the US Department of Agriculture, according to the statement.

In response to a call to action issued by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies